BioSpace News Archive

EdiGene, Inc. and Immunochina announced that they have formed a research and development collaboration to develop allogeneic CAR-T therapy for cancer.

ICON plc announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020.

ORIC Pharmaceuticals, Inc. announced that multiple poster presentations highlighting preclinical data from the company’s glucocorticoid receptor antagonist and CD73 inhibitor programs will be presented at the upcoming American Association for Cancer Research Virtual Annual Meeting II being held June 22-24, 2020.

ViewRay, Inc. announced that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that Company CEO Dwight Egan has been invited to present at The Role of Cell Therapy & Clarity on Testing COVID-19 virtual conference, presented by Maxim Group and M-Vest on Wednesday May 27th, 2020.

Karuna Therapeutics, Inc. announced that data from the Phase 2 clinical trial evaluating KarXT for the treatment of acute psychosis in patients with schizophrenia will be presented at the American Society of Clinical Psychopharmacology 2020 Annual Meeting, to be held virtually from May 29 to May 30, 2020.

ChromaDex joins industry leaders to discuss “What New Dietary Ingredient Master Files Mean for Innovation & Compliance”

The BRIGHT Trial Achieved Statistically Significant and Clinically Meaningful Improvements from Baseline in All Subscales of the Aberrant Behavior Checklist

Annovis Bio Inc. announced that it filed a patent application with the U.S. Patent & Trademark Office concerning a method of inhibiting, preventing, or treating neurological injuries due to viral, bacterial, fungal, protozoan, or parasitic infections in humans and in animals via administration of ANVS401 or related compounds.

Calithera Biosciences, Inc. announced that Susan Molineaux, Ph.D., the company’s founder, president and chief executive officer, will present at the Jefferies Virtual Healthcare Conference at 8:00 a.m. ET on Thursday, June 4, 2020.